US Federal Trade Commission ruling that POM Wonderful Makes False Advertising Claims


Full text copy of the 330-age US FTC ruling that POM Wonderful’s claims about the health benefits of drinking its pomegranate juice constitute false advertising.

From Courthouse News:

“Pom Wonderful makes deceptive advertising claims about the health benefits of drinking its pomegranate juice, a Federal Trade Commission judge ruled….

[W]ithout competent and reasonable scientific evidence, the FTC said Pom can no longer claim that its juice or PomX dietary supplements treat, prevent, or reduce the risk of heart disease, prostate cancer, and erectile dysfunction.

In a September 2010 complaint, the FTC claimed that Pom Wonderful and its sister company, Roll Global, claimed that "clinical studies, research and or/trials prove" that consuming their products had the touted health benefits, when no such evidence exists…

Administrate Law Judge D. Michael Chappell's hearing of the FTC complaint stretched from May 24 to Nov. 4, 2011, and included more than 2,000 exhibits, including testimony from diet and heart health expert Dr. Dean Ornish.

Most of Chappell's 330-page decision examined the scientific evidence on which Pom claims to have relied when making the disputed health claims, as well as the proper standard for making such claims.”

LOADING PDF: If there are any problems, click here to download the file.

Topics:  False Advertising, FDA, FTC, POM Wonderful

Published In: Administrative Agency Updates, Civil Procedure Updates, Civil Remedies Updates, Communications & Media Updates, Conflict of Laws Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© JD Supra Perspectives | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »